The EU Commission conditionally clears a merger between a U.S. healthcare group and a U.S. competitor specialized in cardiovascular medical products (Boston Scientific / Guidant)

"Mergers — Main developments between 1 January and 30 April 2006"* On 11 April the Commission approved the planned acquisition by US healthcare group Boston Scientific Corporation (‘Boston Scientific‘) of its competitor Guidant Corporation

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • JG Associates (Brussels)
  • DG COMP (Brussels)

Quotation

John Gatti, Mary Loughran, The EU Commission conditionally clears a merger between a U.S. healthcare group and a U.S. competitor specialized in cardiovascular medical products (Boston Scientific / Guidant), 11 April 2006, e-Competitions Bulletin April 2006, Art. N° 38272

Visites 237

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues